Personal care formulation
Personal care formulation is provided having multistage polymer, comprising: acrylate rich stage comprising: (a) structural units of monomer selected from C 1-22 alkyl (meth)acrylates and structural units of first carbosiloxane monomer of formula (I); and (b) carbosiloxane rich stage, comprising: structural units of second carbosiloxane monomer of formula (I); wherein a is 0 to 3; wherein d is 0 or 1; wherein R 1 is selected from hydrogen, C 1-10 alkyl group and aryl group; wherein R 2 is selected from hydrogen and C 1-10 alkyl group; wherein R 8 is —O—Si(CH 3 ) 3 group; wherein Y is selected from formula (II), (III) and (IV); wherein R 4 and R 6 are selected from hydrogen and methyl group; wherein R 3 and R 5 are C 1-10 alkylene group; wherein R 7 is C 1-10 alkyl group; wherein b is 0 to 4 and wherein c is 0 or 1; and wherein the first and second carbosiloxane monomer of formula (I) are same or different.
1. A personal care formulation, comprising: a multistage polymer, comprising:
(a) an acrylate rich stage comprising:
63 to 99.9 wt %, based on weight of the acrylate rich stage, of structural units of a monoethylenically unsaturated non-ionic, acrylate rich stage monomer, wherein the monoethylenically unsaturated non-ionic, acrylate rich stage monomer is selected from the group consisting of C 1-22 alkyl (meth)acrylates and mixtures thereof;
0.1 to 25 wt %, based on weight of the acrylate rich stage, of a first carbosiloxane monomer of formula (I)
0 to 10 wt %, based on weight of the acrylate rich stage, of structural units of a monoethylenically unsaturated carboxylic acid, acrylate rich stage monomer; and
0 to 2 wt %, based on weight of the acrylate rich stage, of structural units of a multiethylenically unsaturated, acrylate rich stage monomer having at least two ethylenically unsaturated groups per molecule; and
(b) a carbosiloxane rich stage, comprising:
0 to 90 wt %, based on weight of the carbosiloxane rich stage, of structural units of a vinyl monomer; and
10 to 100 wt %, based on weight of the carbosiloxane rich stage, of structural units of a second carbosiloxane monomer of formula (I)
wherein a is 0 to 3; wherein d is 0 or 1; wherein each R 1 is independently selected from the group consisting of a hydrogen, a C 1-10 alkyl group and an aryl group; wherein each R 2 is independently selected from the group consisting of a hydrogen and a C 1-10 alkyl group; wherein each R 8 is a —O—Si(CH 3 ) 3 group; wherein Y is selected from the group consisting of formula (II), (III) and (IV)
wherein each R 4 and R 6 are independently selected from the group consisting of a hydrogen and a methyl group; wherein each R 3 and R 5 are independently a C 1-10 alkylene group; wherein each R 7 is independently a C 1-10 alkyl group; wherein b is 0 to 4 and wherein c is 0 or 1; and
wherein the first carbosiloxane monomer of formula (I) and the second carbosiloxane monomer of formula (I) are the same or different.
2. The personal care formulation of claim 1 ,
wherein the monoethylenically unsaturated non-ionic, acrylate rich stage monomer is selected from the group consisting of a mixture of C 1-4 alkyl (meth)acrylates;
wherein the monoethylenically unsaturated carboxylic acid, acrylate rich stage monomer is selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, crotonic acid and mixtures thereof;
wherein the multiethylenically unsaturated, acrylate rich stage monomer having at least two ethylenically unsaturated groups per molecule is selected from the group consisting of divinylaromatic compounds, di-(meth)acrylate esters, tri-(meth)acrylate esters, tetra-(methacrylate)esters, di-allyl ethers, tri-allyl ethers, tetra-allyl ethers, di-allyl esters, tri-allyl esters, tetra-allyl esters, allyl (meth)acrylate and mixtures thereof;
wherein the vinyl monomer is selected from the group consisting of a mixture of methacrylic acid and methyl methacrylate;
wherein the first carbosiloxane monomer and the second carbosiloxane monomer are the same; and
wherein a is 1; wherein each R 1 is a methyl group; wherein each R 2 is a methyl group; wherein Y is of formula (II); wherein each R 3 is a C 3-5 alkylene group; and wherein each R 4 is a methyl group.
3. The personal care formulation of claim 2 , further comprising a cosmetically acceptable carrier.
4. The personal care formulation of claim 3 , wherein the cosmetically acceptable carrier includes water.
5. The personal care formulation of claim 4 , further comprising a color ingredient.
6. The personal care formulation of claim 5 , wherein the color ingredient is selected from the group consisting of Ext. D&C Yellow No. 2, Ext. D & C Violet No. 2, FD&C Red No. 4, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6, FD&C Green No. 3, FD&C Blue No. 1, D&C Yellow No. 7, D&C Yellow No. 8, D&C Yellow No. 10, D&C Yellow No. 11, D&C Violet No. 2, D&C Red No. 6, D&C Red No. 7, D&C Red No. 17, D&C Red No. 21, D&C Red No. 22, D&C Red No. 27, D&C Red No. 28, D&C Red No. 30, D&C Red No. 31, D&C Red No. 34, D&C Red No. 33, D&C Red No. 36, D&C Green No. 5, D&C Green No. 6, D&C Green No. 8, D&C Blue No. 4, D&C Orange No. 4, D&C Orange No. 5, D&C Orange No. 10, D&C Orange No. 11, D&C Brown No. 1, Aluminum powder, Annatto, Bismuth citrate, Bismuth Oxychloride, Bronze powder, Caramel, Carmine, β-Carotene, Chromium hydroxide green, Chromium oxide green, Copper chlorophyllin, Copper powder, Dihydroxyacetone, Ferric Ammonium ferrocyanide, Ferric ferrocyanide, Guanine, Iron oxide, Manganese Violet, Mica, Silver, Titanium Dioxide, Ultramarine, Zinc Oxide and mixtures thereof.
7. The personal care formulation of claim 5 , wherein the color ingredient includes at least one iron oxides.
8. The personal care formulation of claim 3 , further comprising a suncare active.
9. The personal care formulation of claim 8 , wherein the suncare active is a UV radiation absorbing agent is selected from the group consisting of physical blockers and chemical absorbers.
10. The personal care formulation of claim 9 , wherein the suncare active is a UV radiation absorbing agent selected from the group consisting of red petrolatum; titanium dioxide; zinc oxide; 1-(4-methoxyphenol)-3-(4-tert-butylphenyl)propane-1,3-dione; 2-hydroxy-4-methoxybenzophenone; dioxybenzone; sulisobenzone; menthyl anthranilate; para-aminobenzoic acid; amyl paradimethylaminobenzoic acid; octyl para-dimethylaminobenzoate; ethyl 4-bis (hydroxypropyl) para-aminobenzoate; polyethylene glycol (PEG-25) para-aminobenzoate; ethyl 4-bis (hydroxypropyl) aminobenzoate; diethanolamine para-methyoxycinnamate; 2-ethoxyethyl para-methoxycinnamate; ethylhexyl para-methoxycinnamate; octyl para-methoxycinnamate; isoamyl para-methoxycinnamate; 2-ethylhexyl-2-cyano-3,3-diphenyl-acrylate; 2-ethylhexyl-2-cyano-3,3-diphenyl-2-propenoate; 2-ethylhexyl-2-hydroxybenzoate; homomenthyl salicylate; glyceryl aminobenzoate; triethanolamine salicylate; digalloyl trioleate; lawsone with dihydroxyacetone; 2-phenylbenzimidazole-5-sulfonic acid; 4-methylbenzylidine camphor; avobenzone; triazines; benzotriazoles; vinyl group-containing amides; cinnamic acid amides; sulfonated benzimidazoles); 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate and mixtures thereof.